Pure Global
Disease/Condition
424 Clinical Trials
10+ Countries

Sickle Cell Disease Clinical Trials Database - Free Access to 424 Studies

Access comprehensive clinical trial information for Sickle Cell Disease through Pure Global AI's free database. This collection includes 424 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 111 trials are actively recruiting participants.

Research for Sickle Cell Disease is being conducted in United States of America, France, Belgium and 7+ other countries. Leading sponsors include St. Jude Children's Research Hospital and Emory University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
225
Phase 2
65
Phase 1
48
Phase 3
30
Early Phase 1
29
By Status
Completed
172
Recruiting
111
Not yet recruit...
40
Terminated
31
Unknown
30
Top Countries
United States of America227
France30
Belgium10
United Kingdom9
Netherlands7
Top Sponsors
St. Jude Children'...21
Emory University19
Assistance Publiqu...17
Global Blood Thera...13
National Heart, Lu...11
Recent Trials
Latest clinical trials for Sickle Cell Disease
NCT06367192
Recruiting

School Readiness Intervention for Preschool Children With Sickle Cell Disease

St. Jude Children's Research H...United States of America
NCT06351462
Not yet recr...

Comparative Health Status and Quality of Life of Patients With Sickle Cell Disease (SCD) Who Underwent Matched-sibling Hematopoietic Stem Cell Transplantation Versus Non Transplanted SCD Case-control Patients

Assistance Publique - Hôpitaux...
NCT06358638
Phase 2
Recruiting

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell AntibodY

Children's National Research I...United States of America
NCT06301893
Recruiting

Uganda Sickle Surveillance Study (US-3)

Children's Hospital Medical Ce...Uganda
NCT06300723
Not yet recr...

Clinical Study of BRL-101 in Severe SCD

Bioray LaboratoriesChina
NCT06293222
Recruitment ...

Patient and Public Involvement and Engagement in Research With Children and Young People With Sickle Cell Disorder and Their Families

King's College LondonUnited Kingdom
NCT06287099
Not yet recr...

Clinical Study of BRL-101 in the Treatment of Sickle Cell Disease

Bioray Laboratories
NCT06287086
Not yet recr...

Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease

Bioray Laboratories
NCT06318143
Not yet recr...

mAnaging siCkle CELl disEase Through incReased AdopTion of hydroxyurEa in Nigeria

New York University
NCT06260891
Phase 2
Not yet recr...

Zinc Supplementation in Sickle Cell Disease

University of California, San ...United States of America
NCT06251843
Not yet recr...

Support Strategies for Parents During the First Year Following Their Child's Diagnosis of Sickle Cell Disorder

King's College London
NCT06264700
Not yet recr...

Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness

Nationwide Children's HospitalUnited States of America
NCT06158945
Recruiting

The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease

Sohag UniversityEgypt
NCT06155500
Not yet recr...

Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)

Novartis Pharmaceuticals
NCT06145282
Phase 1/2
Not yet recr...

Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function

National Heart, Lung, and Bloo...United States of America
NCT06110754
Recruiting

Development and Adaptation of I-STRONG for SCD

Emory UniversityUnited States of America
NCT06074198
Not yet recr...

Sickle Cell Children's Exercise Study (SuCCESs)

University of Maryland, Baltim...
NCT06035939
Not yet recr...

SMYLS Multi-site Trial

Medical University of South Ca...United States of America
NCT06023199
Recruiting

Assessing Physical Function in Sickle Cell Patients Taking Voxelotor

Inova Health Care ServicesUnited States of America
NCT05953584
Phase 2
Recruiting

A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

Novo Nordisk A/SIndia,Nigeria,Oman
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Sickle Cell Disease Research

Pure Global AI provides free access to 424 clinical trials studying Sickle Cell Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include St. Jude Children's Research Hospital, Emory University, Assistance Publique - Hôpitaux de Paris, among others.

Quick Facts
Total Trials424
Countries10+
Sponsors10+
Recruiting111